Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Trishula Therapeutics, Inc.
Cyteir Therapeutics, Inc.
Actuate Therapeutics Inc.
Incyte Corporation
National Institutes of Health Clinical Center (CC)